 |
Advanced Health & Life Extension |
Custom Search
|
|
|
|
|
Advanced Health & Life Extension |
Custom Search
|
|
|
Olive Leaf Extract ReferencesThese references apply to the article, Olive Leaf Extract . Fehri B, Aiache JM, Memmi A, Korbi S, Yacoubi MT, Mrad S, Lamaison JL. Hypotension, hypoglycemia and hypouricemia recorded after repeated administration of aqueous leaf extract of Olea europaea L. J Pharm Belg . 1994;49:101-8. Khayyal MT, el-Ghazaly MA, Abdallah DM, Nassar NN, Okpanyi SN, Kreuter MH. Blood pressure lowering effect of an olive leaf extract ( Olea europaea ) in L-NAME induced hypertension in rats. Arzneimittelforschung . 2002;52:797-802. Ribeiro Rde A, Fiuza de Melo MM, De Barros F, Gomes C, Trolin G. Acute antihypertensive effect in conscious rats produced by some medicinal plants used in the state of Sao Paulo. J Ethnopharmacol . 1986;15:261-9. Zarzuelo A, Duarte J, Jimenez J, Gonzalez M, Utrilla MP. Vasodilator effect of olive leaf. Planta Med . 1991;57:417-9. Fehri B, Aiache JM, Memmi A, et al. Hypotension, hypoglycemia and hypouricemia recorded after repeated administration of aqueous leaf extract of Olea europaea L [in French]. J Pharm Belg . 199449:101-8. Puel C, Mathey J, Agalias A, Kati-Coulibaly S, Mardon J, Obled C, Davicco MJ, Lebecque P, Horcajada MN, Skaltsounis AL, Coxam V. Dose-response study of effect of oleuropein, an olive oil polyphenol, in an ovariectomy/inflammation experimental model of bone loss in the rat. Clin Nutr. 2006 May 30 De Laurentis N, et al. Flavonoids from leaves of Olea europaea L. cultivars. Ann Pharm Fr. 1998;56(6):268-73. Ficarra P, et al. HPLC analysis of oleuropein and some flavonoids in leaf and bud of Olea europaea L. Farmaco. Jun1991;46(6):803-15. PDR for Herbal Medicines, 2nd edition. Montvale, NJ: Medical Economics Company; 2000:557. American Herbal Products Association. Use of Marker Compounds in Manufacturing and Labeling Botanically Derived Dietary Supplements. Silver Spring, MD: American Herbal Products Association; 2001. Ferro-Luzzi A, et al. Changing the Mediterranean diet: effects on blood lipids. Am J Clin Nutr. Nov1984;40(5):1027-37. Kushi LH, et al. Health implications of Mediterranean diets in light of contemporary knowledge. 2. Meat, wine, fats, and oils. Am J Clin Nutr. Jun1995;61(6 Suppl):1416S-1427S. Visoli F, et al. Oleuropein protects low density lipoprotein from oxidation. Life Sciences. 1994;55:1965-71. Soret MG. Antiviral activity of calcium elenolate on parainfluenza infection of hamsters. Antimicrobial Agents and Chemotherapy. 1969;9:160-66. Bisignano G, et al. On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol. J Pharm Pharmacol. Aug1999;51(8):971-4. Petkov V, Manolov P. Pharmacological analysis of the iridoid oleuropein. Drug Res. 1972;22(9):1476-86. Juven B, et al. Studies on the mechanism of the antimicrobial action of oleuropein. J Appl Bact. 1972;35:559. Visioli F, et al. Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sci. 1998;62(6):541-6. Renis HE. In vitro antiviral activity of calcium elenolate. Antimicrob. Agents Chemother. 1970;167-72. Heinze JE, et al. Specificity of the antiviral agent calcium elenolate. Antimicrob Agents Chemother. Oct1975;8(4):421-5. Renis HE. Inactivation of myxoviruses by calcium elenolate. Antimicrob Agents Chemother. Aug1975;8(2):194-9. Hirschman SZ. Inactivation of DNA polymerases of murine leukaemia viruses by calcium elenolate. Nat New Biol. Aug1972;238(87):277-9. Soret MG. Antiviral activity of calcium elenolate on parainfluenza infection of hamsters. Antimicrob Agents Chemother. 1969;9:160-6. Renis HE. In vitro antiviral activity of calcium elenolate. Antimicrob Agents Chemother. 1970;167-72. Zarzuelo A, et al. Vasodilator effect of olive leaf. Planta Med. Oct1991;57(5):417-9. Visioli F, et al. The effect of minor constituents of olive oil on cardiovascular disease: new findings. Nutr Rev. May1998;56(5 Pt 1):142-7. Giugliano D. Dietary antioxidants for cardiovascular prevention. Nutr Metab Cardiovasc Dis. Feb2000;10(1):38-44. Visioli F, et al. Oleuropein protects low density lipoprotein from oxidation. Life Sci. 1994;55(24):1965-71. Petroni A, et al. Inhibition of platelet aggregatiion and eicosanoid production by phenolic components of olive oil. Thromb Res. Apr1995;78(2)151-60. Hansen K, et al. Isolation of an angiotensin converting enzyme (ACE) inhibitor from olea europaea and olea lacea. Phytomedicine. 1996;2:319-325. Bennani-Kabchi N, et al. Effects of Olea europea var. oleaster leaves in hypercholesterolemic insulin-resistant sand rats. Therapie. Nov1999;54(6):717-23. Gonzalez M, et al. Hypoglycemic activity of olive leaf. Planta Medica. 1992;58:513-515. Chimi H, et al. Inhibition of iron toxicity in rat hepatocyte culture by natural phenolic compounds. Tox In Vitro. 1995;9:695-702. Pieroni A, et al. In vitro anti-complementary activity of flavonoids from olive (Olea europaea L.) leaves. Pharmazie. Oct1996;51(10):765-8. PDR for Herbal Medicines, 2nd ed. Montvale, NJ: Medical Economics Company; 2000:557. Martinez A, et al. Identification of a 36-kDa olive-pollen allergen by in vitro and in vivo studies. Allergy. Jun1999;54(6):584-92. Cherif S, Rahal N, Haouala M, et al. A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension. J Pharm Belg . 1996;51:69-71.
  |
|
